Affiliations of speakers and presenters

Cestmir Altaner, Cancer Research Institute Bratislava, Bratislava, Slovakia Wolfgang Berdel, University Medical Center Münster, Münster, Germany Anton Berns, The Netherlands Cancer Institute, Amsterdam, The Netherlands Clara Bloomfield, The Ohio State University, Columbus, OH Tim Brümmendorf, University Medical Center Hamburg, Hamburg, Germany Alan Burnett, School of Medicine, Cardiff University, Cardiff, UK Christian Buske, University Medical Center Munich, Munich, Germany Vincenzo Ciminale, University of Padova, Padova, Italy Carlo Croce, The Ohio State University, Columbus, OH Hervé Dombret, Hôpital Saint-Louis, Paris, France Jesús Duque, University Medical Center Freiburg, Freiburg, Germany Monika Engelhardt, University Medical Center Freiburg, Freiburg, Germany Elihu Estey, MD Anderson Cancer Center, Houston, TX Walter Fiedler, University Medical Center Hamburg, Hamburg, Germany Thomas Fischer, University Medical Center Mainz, Mainz, Germany Robert Gallo, Institute of Human Virology, University of Maryland, MD Aristoteles Giagounidis, Johannes Hospital, Duisburg, Germany Gerald Gitsch, University Medical Center Freiburg, Freiburg, Germany John Goldman, Imperial College at Hammersmith Hospital, London, UK Steven Gore, Johns Hopkins University, Baltimore, MD Björn Hackanson, University Medical Center Freiburg, Freiburg, Germany Rüdiger Hehlmann, University Medical Center Mannheim, Mannheim, Germany Wolfgang Hiddemann, University Medical Center Munich, Munich, Germany Anthony Ho, University Medical Center Heidelberg, Heidelberg, Germany Mark Kirschbaum, City of Hope Hospital, Duarte, CA Thoma Klag, University Medical Center Mannheim, Mannheim, Germany Philipp Koeffler, Cedars-Sinai Medical Center, Los Angeles, CA Michael Lairmore, The Ohio State University, Columbus, OH Andreas Mackensen, University Medical Center Regensburg, Regensburg, Germany Guido Marcucci, The Ohio State University, Columbus, OH Jean-Pierre Marie, Hôtel Dieu Hospital, Paris, France Reinhard Marks, University Medical Center Freiburg, Freiburg, Germany Maria Mateos, University Medical Center Salamanca, Salamanca, Spain Richard McCaffrey, Dana-Farber Cancer Institute, Boston, MD Karin Moelling, Institute of Medical Virology, University of Zurich, Zurich, Switzerland Richard Momparler, Department of Pharmacology, University of Montreal, Montreal, Canada Malcolm Moore, Sloan-Kettering Institute, New York, NY Clara Nervi, University Medical Center Rome, Rome, Italy Stephen Nimer, Sloan-Kettering Institute, New York, NY Oliver Ottmann, University Medical Center Frankfurt, Frankfurt, Germany Heike Pahl, University Medical Center Freiburg, Freiburg, Germany Christoph Plass, The Ohio State University, Columbus, OH Herbert Pfister, University Medical Center Cologne, Cologne, Germany Michael Pfreundschuh, University Medical Center Homburg, Homburg, Germany Ulf Rapp, Institute for Medical Radiation and Cell Research, Würzburg, Germany Andreas Reiter, University Medical Center Mannheim, Mannheim, Germany Björn Rüter, University Medical Center Freiburg, Freiburg, Germany Giuseppe Saglio, Department of Biological Sciences, University of Turin, Turin, Italy Miguel Sanz, University Hospital La Fe, Valencia, Spain Yuval Shaked, Sunnybrook Health Sciences Center, Toronto, Canada Radek Skoda, University Hospital Basel, Basel, Switzerland Jan Svoboda, Institute of Molecular Genetics, University of Prague, Prague, Czech Republic Dan Tenen, Harvard Institute of Medicine, Boston, MD Axel Ullrich, Max Planck Institute for Biochemistry, Martinsried, Germany Hendrik Veelken, University Medical Center Freiburg, Freiburg, Germany Roel Willemze, University Medical Center Leiden, Leiden, The Netherlands Junji Yodoi, Institute for Virus Research, Kyoto University, Kyoto, Japan Robert Zeiser, Stanford University, Palo Alto, CA Dong-Er Zhang, Department of Molecular and Experimental Medicine, La Jolla, CA

ACKNOWLEGMENTS We wish to thank all the session chairs, speakers and all other participants for their contribution to this successful meeting. The Deutsche Forschungsgemeinschaft, The European Leukemia Network and the German Competence Network "Leukemias", German José- Carreras Leukemia Foundation, MDS Foundation, BioThera Foundation and all other sponsors are gratefully acknowledged for support (list of sponsors: www.iacrlrd.de). We also wish to thank S & K Grey for excellent organizational support. BH, CD and RZ are currently supported by grants from the Forschungskommission Freiburg; TB and ML are supported by grants from the German José Carreras Leukemia Foundation; RZ is supported by a grant from the Dr. Mildred Scheel Foundation for Cancer Research.